These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 1194964

  • 21. Comparison of 99mTc complexes for renal imaging.
    Arnold RW, Subramanian G, McAfee JG, Blair RJ, Thomas FD.
    J Nucl Med; 1975 May; 16(5):357-67. PubMed ID: 1194986
    [Abstract] [Full Text] [Related]

  • 22. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C, Hohloch M, Hoffmann G.
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [Abstract] [Full Text] [Related]

  • 23. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V, Kumar D, Howman-Giles RB, Little DG.
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [Abstract] [Full Text] [Related]

  • 24. Bone scintigraphy with 99mTc-labelled polyphosphate.
    Edeling CJ.
    Nucl Med (Stuttg); 1974 Aug 31; 13(2):113-26. PubMed ID: 4612487
    [No Abstract] [Full Text] [Related]

  • 25. Technetium-99m-labeled stannous ethane-1-hydroxy-1 1-diphosphonate: a new bone scanning agent.
    Yano Y, McRae J, Van Dyke DC, Anger HO.
    J Nucl Med; 1973 Feb 31; 14(2):73-8. PubMed ID: 4683211
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of technetium-99m diphosphonate.
    Castronovo FP, Guiberteau MJ, Berg G, McKusick KA, Callahan RJ, Potsaid MS.
    J Nucl Med; 1977 Aug 31; 18(8):809-14. PubMed ID: 874170
    [Abstract] [Full Text] [Related]

  • 27. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
    Schümichen C, Hohloch H, Schiller A, Pohle W, Hoffmann G.
    Nuklearmedizin; 1979 May 31; 18(2):98-104. PubMed ID: 38438
    [Abstract] [Full Text] [Related]

  • 28. Cardiac changes with 99mTc-tin-phosphate radiopharmaceuticals.
    Stevenson JS, Dunson GL.
    J Nucl Med; 1973 Oct 31; 14(10):774-5. PubMed ID: 4743588
    [No Abstract] [Full Text] [Related]

  • 29. Distribution of 99mTc-Sn diphosphonate and free 99mTc-pertechnetate in selected soft and hard tissues.
    Silberstein EB, Francis MD, Tofe AJ, Slough CL.
    J Nucl Med; 1975 Jan 31; 16(1):58-61. PubMed ID: 162948
    [Abstract] [Full Text] [Related]

  • 30. New 68Ga-labeled skeletal-imaging agents for positron scintigraphy.
    Dewanjee MK, Hnatowich DJ, Beh R.
    J Nucl Med; 1976 Nov 31; 17(11):1003-7. PubMed ID: 978248
    [Abstract] [Full Text] [Related]

  • 31. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J, Montz R.
    Nuklearmedizin; 1983 Oct 31; 22(5):226-31. PubMed ID: 6228781
    [Abstract] [Full Text] [Related]

  • 32. Comparison of 18F and 99mTc-polyphosphate in orthopedic bone scintigraphy.
    Heerfordt J, Vistisen L, Bohr H.
    J Nucl Med; 1976 Feb 31; 17(02):98-103. PubMed ID: 173816
    [Abstract] [Full Text] [Related]

  • 33. [Bone scanning with 99m-Tc-polyphosphate and strontium isotopes (author's transl)].
    Creutzig H, Hundeshagen H.
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Nov 31; 119(5):560-8. PubMed ID: 4360988
    [No Abstract] [Full Text] [Related]

  • 34. Phosphate compounds in bone scanning.
    Hughes SP, Jeyasingh K, Lavender PJ.
    J Bone Joint Surg Br; 1975 May 31; 57(2):214-6. PubMed ID: 1141288
    [Abstract] [Full Text] [Related]

  • 35. Technetium-99m stannous citrate brain-tumor uptake in mice: concise communication.
    Haynie TP, Konikowski T, Glenn HJ.
    J Nucl Med; 1977 Sep 31; 18(9):915-8. PubMed ID: 893790
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
    Fritzberg AR, Lyster DM, Dolphin DH.
    J Nucl Med; 1977 Jun 31; 18(6):553-7. PubMed ID: 192859
    [Abstract] [Full Text] [Related]

  • 37. Comparison of 99mTc-labelled polyphosphate, pyrophosphate and ethane hydroxy diphosphonate in patients with skeletal metastases and in normal subjects.
    Citrin DL, Bessent RG, Tuohy JB, Elms ST, McGinlay E, Greig WR, Blumgart LH.
    Strahlentherapie Sonderb; 1975 Jun 31; 74():321-8. PubMed ID: 173049
    [No Abstract] [Full Text] [Related]

  • 38. Method for the synthesis of the skeletal seeking agent 1-hydroxy-ethylidene-1,1-disodium phosphonate (HEDSPA) and its subsequent labelling with 99mTc.
    Castronovo FP.
    Int J Nucl Med Biol; 1973 Nov 31; 1(2):109-13. PubMed ID: 4803260
    [No Abstract] [Full Text] [Related]

  • 39. 99m Tc-labeled polyphosphate as a skeletal imaging agent.
    Subramanian G, McAfee JG, Bell EG, Blair RJ, O'Mara RE, Ralston PH.
    Radiology; 1972 Mar 31; 102(3):701-4. PubMed ID: 5060184
    [No Abstract] [Full Text] [Related]

  • 40. Optimization of the ratio of stannous tin: ethane-1-hydroxy-1, 1-diphosphonate for bone scanning with 99mTc-pertechnetate.
    Tofe AJ, Francis MD.
    J Nucl Med; 1974 Feb 31; 15(2):69-74. PubMed ID: 4810592
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.